Alpha-fetoprotein (AFP) is a well-known biomarker for hepatocellular carcinoma, but a problem is that serum AFP levels are increased in patients with liver cirrhosis and chronic hepatitis [5]. This evidence concerns the gene AFP and chronic hepatitis.